The first biotechnology product - Health Beat - Food and Drug Administration approves Omalizumab for treatment of asthma - Brief Article

USA Today (Society for the Advancement of Education), Feb, 2004

The first biotechnology product to treat patients with a type of asthma that is related to allergies has been approved by the Food and Drug Administration. Omalizumab is a monoclonal antibody shown to be effective in treating people 12 years of age and older with moderate to severe allergy-related asthma inadequately controlled with inhaled steroid treatments.

It decreases the number of airway-narrowing episodes that result in wheezing, breathlessness, and cough.

COPYRIGHT 2004 Society for the Advancement of Education
COPYRIGHT 2004 Gale Group

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale